Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Perilunate Management

Not Applicable

Recruiting

Conditions: Perilunate Injury

Interventions: Procedure: Open Surgery
Procedure: Arthroscopic surgery

First Posted Date: 2023-04-21

Last Posted Date: 2025-04-17

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT05824078

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

Effect of Personalized Pain Coaches After Orthopaedic Surgery for Patients With Sports Medicine Injuries

Not Applicable

Recruiting

Conditions: Sports Medicine Injuries

Interventions: Behavioral: LCS (Life Care Specialist)
Behavioral: Standard of Care

First Posted Date: 2023-04-20

Last Posted Date: 2023-09-14

Lead Sponsor: Emory University

Target Recruit Count: 150

Registration Number: NCT05821699

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Orthopaedics and Spine Center, Atlanta, Georgia, United States

Web-based Physical Activity Intervention to Promote Physical Activity

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Behavioral: PATH Intervention
Behavioral: Attention Control Intervention
Other: Physical activity tracker
Behavioral: Dietary education

First Posted Date: 2023-04-07

Last Posted Date: 2025-03-30

Lead Sponsor: Emory University

Target Recruit Count: 89

Registration Number: NCT05803304

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Durability of Vaccine Responses

Phase 4

Recruiting

Conditions: Vaccine Response

Interventions: Biological: Live Attenuated Yellow Fever 17D Vaccine
Biological: Quadrivalent seasonal influenza vaccine

First Posted Date: 2023-04-06

Last Posted Date: 2025-07-01

Lead Sponsor: Emory University

Target Recruit Count: 66

Registration Number: NCT05801978

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
The Hope Clinic of Emory University, Decatur, Georgia, United States

Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

Early Phase 1

Recruiting

Conditions: Recurrent Glioblastoma
Glioblastoma

Interventions: Procedure: Biospecimen Collection
Drug: Avutometinib
Drug: Defactinib

First Posted Date: 2023-04-04

Last Posted Date: 2024-08-27

Lead Sponsor: Emory University

Target Recruit Count: 12

Registration Number: NCT05798507

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

An Adaptive Prenatal Intervention to Increase Childhood Vaccinations

Not Applicable

Recruiting

Conditions: Vaccination Refusal

Interventions: Behavioral: ADEPT

First Posted Date: 2023-04-03

Last Posted Date: 2024-08-28

Lead Sponsor: Emory University

Target Recruit Count: 770

Registration Number: NCT05795855

Locations: 🇺🇸
Duke Health System, Durham, North Carolina, United States

DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)

Recruiting

Conditions: Stroke, Ischemic

Interventions: Device: wearable wristband model
Device: Standard of care extended ECG monitoring

First Posted Date: 2023-04-03

Last Posted Date: 2024-12-18

Lead Sponsor: Emory University

Target Recruit Count: 500

Registration Number: NCT05795842

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States

Sentinel Cohort REACT

Phase 1

Completed

Conditions: Multi-Drug Resistant Organism

Interventions: Drug: Allogeneic Microbiota in Glycerol (10%) (AMG)

First Posted Date: 2023-03-23

Last Posted Date: 2024-03-28

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT05780801

Locations: 🇺🇸
Emory Long-Term Acute Care, Decatur, Georgia, United States

Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Adenocarcinoma
Recurrent Prostate Carcinoma

Interventions: Drug: Furosemide
Other: F18-rhPSMA-7.3
Procedure: Positron Emission Tomography
Procedure: Computed Tomography

First Posted Date: 2023-03-22

Last Posted Date: 2024-07-03

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT05779943

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

and more 1 locations

Caregiving While Black

Not Applicable

Recruiting

Conditions: Caregiver Burden

Interventions: Other: Caring While Black
Other: Usual Care

First Posted Date: 2023-03-16

Last Posted Date: 2025-05-14

Lead Sponsor: Emory University

Target Recruit Count: 140

Registration Number: NCT05772689

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy